Monday’s Highlights at Noon: Halcon Resources (HK), NovaBay Pharma (NBY), Amira Nature (ANFI), Anthera Pharmaceuticals (ANTH), Can-Fite BioPharma (CANF)

By Carrie Williams

So far Monday, May 13, NASDAQ is down -4.77% and the S&P is down -2.07%. Here are this morning’s most active stocks: Halcon Resources (HKResearch Report), NovaBay Pharma (NBYResearch Report), Amira Nature (ANFIResearch Report), Anthera Pharmaceuticals (ANTHResearch Report) and Can-Fite BioPharma (CANFResearch Report).

Halcon Resources is down -42.2% in midday trading to $0.35. Shares opened today at $0.61. The company has a 52-week low of $0.33 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $4.00, marking a 556.81% potential upside from current levels. In a report released today, Imperial analyst Jason Wangler maintained a Hold rating on HK, with a price target of $1, which represents a potential upside of 64% from where the stock is currently trading.

NovaBay Pharma is down -27.78% in midday trading to $0.36. Shares opened today at $0.50. The company has a 52-week low of $0.30 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $1.25, marking a 148.02% potential upside from current levels. In a report issued on March 29, H.C. Wainwright analyst Ram Selvaraju reiterated a Hold rating on NBY, with a price target of $1, which represents a potential upside of 98% from where the stock is currently trading.

Amira Nature is down -16.42% in midday trading to $1.12. Shares opened today at $1.34. The company has a 52-week low of $0.30 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $6.00, marking a 347.76% potential upside from current levels. In a report issued on March 21, Jefferies Co. analyst Akshay Jagdale assigned a Buy rating on ANFI, with a price target of $6, which implies an upside of 348% from current levels.

See today’s analyst top recommended stocks >>

Anthera Pharmaceuticals is down -16.09% in midday trading to $0.08. Shares opened today at $0.09. The company has a 52-week low of $0.01 and a 52-week high of $0.00.

See today’s analyst top recommended stocks >>

Can-Fite BioPharma is down -11.5% in midday trading to $6.00. Shares opened today at $6.78. The company has a 52-week low of $5.65 and a 52-week high of $0.00. On the Street’s front, the average 12-month analyst price target for the stock is $30.00, marking a 342.48% potential upside from current levels. In a report issued on May 9, H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating on CANF, with a price target of $30, which represents a potential upside of 342% from where the stock is currently trading.

Trending Stocks Based on Insider Activity >>